Literature DB >> 29563612

Helicobacter pylori infection promotes Aquaporin 3 expression via the ROS-HIF-1α-AQP3-ROS loop in stomach mucosa: a potential novel mechanism for cancer pathogenesis.

Jianfei Wen1, Yao Wang1, Cheng Gao1, Guoxin Zhang2, Qiang You3, Weiming Zhang4, Zhihong Zhang4, Shoulin Wang5, Guangyong Peng6, Lizong Shen7.   

Abstract

Helicobacter pylori (H. pylori) is the major stomach carcinogen, but the molecular mechanism responsible for the pathogenesis of cancer development mediated by H. pylori infection is still unclear. Aquaporin 3 (AQP3), overexpressed in gastric carcinoma, has a crucial role in gastric carcinogenesis and progression. However, the triggers and precise regulations for AQP3 upregulation during gastric carcinogens also remain unknown. Here we report that H. pylori infection-mediated carcinogenesis may be mechanistically depended on the upregulation of AQP3 expression via reactive oxygen species (ROS) pathway activation in the stomach. The retrospective analyses of clinical samples from patients with gastric carcinoma and other different stages of gastric diseases indicated that AQP3 expression was positively associated with gastric mucosal disease progression and H. pylori infection status as well. Furthermore, H. pylori infection significantly upregulated AQP3 and HIF-1α expression and increased ROS amount in human gastric epithelial AGS and GES-1 cells. Blockage of ROS with inhibitors, NAC and DPI, markedly decreased the expression of AQP3 and HIF-1α in both AGS and GES-1 cells simultaneously. Furthermore, the increased AQP3 in cells was mechanistically due to the transcriptional regulation by HIF-1α. In addition, H. pylori infection exerted production of proinflammatory cytokines IL-6, IL-8, and TNF depending on AQP3 level. Importantly, these in vitro novel findings were further investigated in vivo in a mouse H. pylori infectious model. Our current studies identify the mechanistic link between H. pylori infection and AQP3 upregulation in the pathogenesis of gastric carcinoma, which involves the activation of the ROS-HIF-1α axis and the exacerbated ROS-HIF-1α-AQP3-ROS loop.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29563612     DOI: 10.1038/s41388-018-0208-1

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  47 in total

Review 1.  Synergistic interaction between Helicobacter pylori gastritis and diet in gastric cancer.

Authors:  N Yamaguchi; T Kakizoe
Journal:  Lancet Oncol       Date:  2001-02       Impact factor: 41.316

Review 2.  Environmental immune disruptors, inflammation and cancer risk.

Authors:  Patricia A Thompson; Mahin Khatami; Carolyn J Baglole; Jun Sun; Shelley A Harris; Eun-Yi Moon; Fahd Al-Mulla; Rabeah Al-Temaimi; Dustin G Brown; Annamaria Colacci; Chiara Mondello; Jayadev Raju; Elizabeth P Ryan; Jordan Woodrick; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Rabindra Roy; Stefano Forte; Lorenzo Memeo; Hosni K Salem; Amedeo Amedei; Roslida A Hamid; Leroy Lowe; Tiziana Guarnieri; William H Bisson
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

Review 3.  Glucose metabolism in gastric cancer: The cutting-edge.

Authors:  Lian-Wen Yuan; Hiroharu Yamashita; Yasuyuki Seto
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

Review 4.  Pathogenesis of Helicobacter pylori infection.

Authors:  Steffen Backert; Matthias Neddermann; Gunter Maubach; Michael Naumann
Journal:  Helicobacter       Date:  2016-09       Impact factor: 5.753

5.  Modification of Helicobacter pylori Peptidoglycan Enhances NOD1 Activation and Promotes Cancer of the Stomach.

Authors:  Giovanni Suarez; Judith Romero-Gallo; M Blanca Piazuelo; Ge Wang; Robert J Maier; Lennart S Forsberg; Parastoo Azadi; Martin A Gomez; Pelayo Correa; Richard M Peek
Journal:  Cancer Res       Date:  2015-03-02       Impact factor: 12.701

6.  Mechanism of hypoxia-inducible factor 1 alpha-mediated Mcl1 regulation in Helicobacter pylori-infected human gastric epithelium.

Authors:  Asima Bhattacharyya; Ranajoy Chattopadhyay; Emily H Hall; Semret T Mebrahtu; Peter B Ernst; Sheila E Crowe
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2010-09-09       Impact factor: 4.052

Review 7.  Helicobacter pylori: a ROS-inducing bacterial species in the stomach.

Authors:  Osamu Handa; Yuji Naito; Toshikazu Yoshikawa
Journal:  Inflamm Res       Date:  2010-09-05       Impact factor: 4.575

Review 8.  Interdependence of hypoxic and innate immune responses.

Authors:  Victor Nizet; Randall S Johnson
Journal:  Nat Rev Immunol       Date:  2009-09       Impact factor: 53.106

Review 9.  Aquaporins: important but elusive drug targets.

Authors:  Alan S Verkman; Marc O Anderson; Marios C Papadopoulos
Journal:  Nat Rev Drug Discov       Date:  2014-03-14       Impact factor: 84.694

Review 10.  Global burden of cancers attributable to infections in 2008: a review and synthetic analysis.

Authors:  Catherine de Martel; Jacques Ferlay; Silvia Franceschi; Jérôme Vignat; Freddie Bray; David Forman; Martyn Plummer
Journal:  Lancet Oncol       Date:  2012-05-09       Impact factor: 41.316

View more
  14 in total

1.  Siah2-GRP78 interaction regulates ROS and provides a proliferative advantage to Helicobacter pylori-infected gastric epithelial cancer cells.

Authors:  Pragyesh Dixit; Swathi Shivaram Suratkal; Shrikant Babanrao Kokate; Debashish Chakraborty; Indrajit Poirah; Supriya Samal; Niranjan Rout; Shivaram P Singh; Arup Sarkar; Asima Bhattacharyya
Journal:  Cell Mol Life Sci       Date:  2022-07-11       Impact factor: 9.207

2.  Construction and preservation of a stable and highly expressed recombinant Helicobacter pylori vacuolating cytotoxin A with apoptotic activity.

Authors:  Ling-Zhi Yuan; Xiao Shi; Dan Tang; Shao-Peng Zheng; Zhi-Ming Xiao; Fen Wang
Journal:  BMC Microbiol       Date:  2021-08-18       Impact factor: 3.605

3.  Cancer-associated fibroblasts-derived VCAM1 induced by H. pylori infection facilitates tumor invasion in gastric cancer.

Authors:  Jiajia Shen; Jing Zhai; Qiang You; Guoxin Zhang; Mingfang He; Xuequan Yao; Lizong Shen
Journal:  Oncogene       Date:  2020-02-07       Impact factor: 8.756

4.  Helicobacter pylori upregulates TRPC6 via Wnt/β-catenin signaling to promote gastric cancer migration and invasion.

Authors:  Yang Song; Gao Liu; Shuang Liu; Rong Chen; Na Wang; Zhaoyu Liu; Xiao Zhang; Zheng Xiao; Lin Liu
Journal:  Onco Targets Ther       Date:  2019-07-03       Impact factor: 4.147

Review 5.  Oxygen-dependent regulation of ion channels: acute responses, post-translational modification, and response to chronic hypoxia.

Authors:  Hae Young Yoo; Sung Joon Kim
Journal:  Pflugers Arch       Date:  2021-06-17       Impact factor: 3.657

6.  MiR-877 suppresses gastric cancer progression by downregulating AQP3.

Authors:  Hongyu Zhu; Yulian Wu; Muxing Kang; Bo Zhang
Journal:  J Int Med Res       Date:  2020-06       Impact factor: 1.671

7.  Involvement of Aryl Hydrocarbon Receptor and Aryl Hydrocarbon Receptor Repressor in Helicobacter Pylori-related Gastric Pathogenesis.

Authors:  Renfei Zhu; Cheng Gao; Liuhua Wang; Guoxin Zhang; Weiming Zhang; Zhihong Zhang; Lizong Shen; Shoulin Wang
Journal:  J Cancer       Date:  2018-07-01       Impact factor: 4.207

8.  Helicobacter pylori-induced exosomal MET educates tumour-associated macrophages to promote gastric cancer progression.

Authors:  Ying Che; Biao Geng; Yue Xu; Xin Miao; Ling Chen; Xianmin Mu; Jinshun Pan; Chen Zhang; Ting Zhao; Chao Wang; Xiang Li; Hao Wen; Zheng Liu; Qiang You
Journal:  J Cell Mol Med       Date:  2018-08-30       Impact factor: 5.310

9.  Long non-coding RNA SNHG17 promotes gastric cancer progression by inhibiting P15 and P16.

Authors:  Cheng Gao; Xinqian Wu; Jing Zhai; Jiajia Shen; Shoulin Wang; Lizong Shen
Journal:  Transl Cancer Res       Date:  2019-04       Impact factor: 1.241

10.  Low expression of AQP9 and its value in hepatocellular carcinoma.

Authors:  Cheng Gao; Jianbo Shen; Lanqing Yao; Zhenguo Xia; Xiaoliang Liang; Renfei Zhu; Zhong Chen
Journal:  Transl Cancer Res       Date:  2021-04       Impact factor: 1.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.